drugset / Trial / NCT00538525

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

NCT00538525

NaSingle-groupOpen-labelTreatment

Summary

Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer

Timeline

Start
2007-09
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified
Comparator Docetaxel Small molecule
Comparator Doxorubicin Other / unclassified

Indications